• Issue

    European Journal of Heart Failure: Volume 14, Issue 9

    955-1074
    September 2012
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Editorial

Free Access

Why do drugs for acute heart failure fail?

Adriaan A. Voors,  Dirk J. van Veldhuisen, 
  • Pages: 955-956
  • First Published: 27 February 2014

Epidemiology

Free Access

Progression of left atrial volume index in a population at risk for heart failure: a substudy of the STOP-HF (St Vincent's Screening TO Prevent Heart Failure) trial

Patrick Collier,  Chris J. Watson,  Deidre F. Waterhouse,  Ian R. Dawkins,  Anil K. Patle,  Stephen Horgan,  Carmel M. Conlon,  Rory O'Hanlon,  John A. Baugh,  Mark T. Ledwidge,  Kenneth McDonald, 
  • Pages: 957-964
  • First Published: 27 February 2014

Biomarkers

Free Access

Increased Rho kinase activity in congestive heart failure

Ming Dong,  James K. Liao,  Fang Fang,  Alex Pui-Wai Lee,  Bryan Ping-Yen Yan,  Ming Liu,  Cheuk-Man Yu, 
  • Pages: 965-973
  • First Published: 27 February 2014
Free Access

Differential mortality association of loop diuretic dosage according to blood urea nitrogen and carbohydrate antigen 125 following a hospitalization for acute heart failure

Julio Núñez,  Eduardo Núñez,  Gema Miñana,  Vicent Bodí,  Gregg C. Fonarow,  Vicente Bertomeu-González,  Patricia Palau,  Pilar Merlos,  Silvia Ventura,  Francisco J. Chorro,  Pau Llàcer,  Juan Sanchis, 
  • Pages: 974-984
  • First Published: 27 February 2014
Free Access

Relations of circulating vitamin D concentrations with left ventricular geometry and function

Tove Fall,  Ivy Shiue,  Per Bergeå af Geijerstam,  Johan Sundström,  Johan Ärnlöv,  Anders Larsson,  Håkan Melhus,  Lars Lind,  Erik Ingelsson, 
  • Pages: 985-991
  • First Published: 27 February 2014
Free Access

Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials

Roberto Latini,  Lars Gullestad,  Serge Masson,  Ståle Haugset Nymo,  Thor Ueland,  Ivan Cuccovillo,  Mari Vårdal,  Barbara Bottazzi,  Alberto Mantovani,  Donata Lucci,  Nobuhito Masuda,  Yukio Sudo,  John Wikstrand,  Gianni Tognoni,  Pål Aukrust,  Luigi Tavazzi,  on behalf of the Investigators of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA) and GISSI-Heart Failure (GISSI-HF) trials , 
  • Pages: 992-999
  • First Published: 27 February 2014

Diagnosis

Free Access

Development and initial validation of a simple clinical decision tool to predict the presence of heart failure in primary care: the MICE (Male, Infarction, Crepitations, Edema, MICE) rule

Andrea K. Roalfe,  Jonathan Mant,  Jenny A. Doust,  Pelham Barton,  Martin R. Cowie,  Paul Glasziou,  David Mant,  Richard J. McManus,  Roger Holder,  Jonathan J. Deeks,  Robert N. Doughty,  Arno W. Hoes,  Kate Fletcher,  F.D. Richard Hobbs, 
  • Pages: 1000-1008
  • First Published: 27 February 2014

Prognosis

Free Access

Prognostic impact of sleep-disordered breathing and its treatment with nocturnal ventilation for chronic heart failure

Thibaud Damy,  Laurent Margarit,  Ala Noroc,  Diane Bodez,  Soulef Guendouz,  Laurent Boyer,  Xavier Drouot,  Aurélia Lamine,  Alexandra Paulino,  Stéphane Rappeneau,  Maria-Hermann Stoica,  Jean-Luc Dubois-Randé,  Serge Adnot,  Luc Hittinger,  Marie Pia d'Ortho, 
  • Pages: 1009-1019
  • First Published: 27 February 2014
Free Access

Elevated urinary neutrophil gelatinase-associated lipocalcin after acute heart failure treatment is associated with worsening renal function and adverse events

Sean P. Collins,  Kimberly W. Hart,  Christopher J. Lindsell,  Gregory J. Fermann,  Neal L. Weintraub,  Karen F. Miller,  Susan N. Roll,  Matthew I. Sperling,  Douglas B. Sawyer,  Alan B. Storrow, 
  • Pages: 1020-1029
  • First Published: 27 February 2014
Free Access

The importance of whether atrial fibrillation or heart failure develops first

Marcelle D. Smit,  Marjolein L. Moes,  Alexander H. Maass,  Ismaël D. Achekar,  Peter P. Van Geel,  Hans L. Hillege,  Dirk J. van Veldhuisen,  Isabelle C. Van Gelder, 
  • Pages: 1030-1040
  • First Published: 27 February 2014

Comorbidity

Free Access

Targeted intervention improves knowledge but not self-care or readmissions in heart failure patients with mild cognitive impairment

Karen K. Davis,  Miriam Mintzer,  Cheryl R. Dennison Himmelfarb,  Matthew J. Hayat,  Stacey Rotman,  Jerilyn Allen, 
  • Pages: 1041-1049
  • First Published: 27 February 2014

Treatment

Free Access

MitraClip therapy in daily clinical practice: initial results from the German transcatheter mitral valve interventions (TRAMI) registry

Stephan Baldus,  Wolfgang Schillinger,  Olaf Franzen,  Raffi Bekeredjian,  Horst Sievert,  Joachim Schofer,  Karl-Heinz Kuck,  Thomas Konorza,  Helge Möllmann,  Christoph Hehrlein,  Taoufik Ouarrak,  Jochen Senges,  Thomas Meinertz,  for the German Transcatheter Mitral Valve Interventions (TRAMI) investigators , 
  • Pages: 1050-1055
  • First Published: 27 February 2014
Free Access

Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromes†

Mihai Gheorghiade,  Stephen J. Greene,  Gerasimos Filippatos,  Erland Erdmann,  Roberto Ferrari,  Phillip D. Levy,  Aldo Maggioni,  Christina Nowack,  Alexandre Mebazaa,  on behalf of the COMPOSE Investigators and Coordinators , 
  • Pages: 1056-1066
  • First Published: 27 February 2014
Free Access

Sildenafil enhances systolic adaptation, but does not prevent diastolic dysfunction, in the pressure-loaded right ventricle

Marinus A.J. Borgdorff,  Beatrijs Bartelds,  Michael G. Dickinson,  Bibiche Boersma,  Michel Weij,  Andre Zandvoort,  Herman H.W. Silljé,  Paul Steendijk,  Maartje de Vroomen,  Rolf M.F. Berger, 
  • Pages: 1067-1074
  • First Published: 27 February 2014